{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:16:12Z","timestamp":1761765372580},"reference-count":23,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1492,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1177\/0091270010379410","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T03:24:11Z","timestamp":1294284251000},"page":"1195-1204","source":"Crossref","is-referenced-by-count":19,"title":["Pharmacokinetics, Safety, and Tolerability of Ascending Doses of Sublingual Fentanyl, With and Without Naltrexone, in Japanese Subjects"],"prefix":"10.1002","volume":"51","author":[{"given":"Nicola","family":"Lister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Warrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Tamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kilborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"10.1177\/0091270010379410-BIB1|cit1","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jpainsymman.2005.01.009","article-title":"Fentanyl","volume":"29","author":"Stanley","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1177\/0091270010379410-BIB2|cit2","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"Gutstein","year":"2006"},{"key":"10.1177\/0091270010379410-BIB3|cit3","first-page":"6","volume-title":"Actiq Monograph","author":"Cephalon UK Ltd.","year":"2006"},{"key":"10.1177\/0091270010379410-BIB4|cit4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/14656560902851510","article-title":"Treatment strategies for cancer patients with breakthrough pain","volume":"10","author":"Casuccio","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1177\/0091270010379410-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2165\/00003088-200544120-00006","article-title":"Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers","volume":"44","author":"Darwish","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1177\/0091270010379410-BIB6|cit6","first-page":"1072","article-title":"Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy and drug interactions","volume":"25","author":"Labroo","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1177\/0091270010379410-BIB7|cit7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000542-199802000-00006","article-title":"Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate","volume":"88","author":"Streisand","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1177\/0091270010379410-BIB8|cit8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000542-200003000-00009","article-title":"Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers","volume":"92","author":"Egan","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1177\/0091270010379410-BIB9|cit9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.clinthera.2006.05.015","article-title":"Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 \u03bcg in healthy adult volunteers","volume":"28","author":"Darwish","year":"2006","journal-title":"Clin Ther"},{"key":"10.1177\/0091270010379410-BIB10|cit10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0091270006294129","article-title":"Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers","volume":"47","author":"Darwish","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1177\/0091270010379410-BIB11|cit11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/00044011-200727090-00002","article-title":"Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study","volume":"27","author":"Darwish","year":"2007","journal-title":"Clin Drug Investig"},{"key":"10.1177\/0091270010379410-BIB12|cit12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.2004.02264.x","article-title":"Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain","volume":"59","author":"Lennern\u00e4s","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1177\/0091270010379410-BIB13|cit13","unstructured":"Lorch U Farrell F Kilborn J Tamaoka M Derrick R Howell J. Pharmacokinetics and tolerability of sublingual fentanyl in healthy Japanese and Caucasian volunteers: phase I, open-label, single-dose study. Abstract WSPC01-027"},{"key":"10.1177\/0091270010379410-BIB14|cit14","volume-title":"Sublingual fentanyl (Abstral) [summary of product characteristics]","year":"2008"},{"key":"10.1177\/0091270010379410-BIB15|cit15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.clpt.6100482","article-title":"Pharmacokinetics\/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations","volume":"84","author":"Myrand","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1177\/0091270010379410-BIB16|cit16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/rcm.255","article-title":"A highly automated 96-well solid phase extraction and liquid chromatography\/tandem mass spectrometry method for the determination of fentanyl in human plasma","volume":"15","author":"Shou","year":"2001","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1177\/0091270010379410-BIB17|cit17","unstructured":"WinNonlin Pharsight Corporation"},{"key":"10.1177\/0091270010379410-BIB18|cit18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/js980258b","article-title":"Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system","volume":"8","author":"Gupta","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1177\/0091270010379410-BIB19|cit19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/j.1552-4604.1998.tb04392.x","article-title":"Fentanyl delivery from an electrotransport system: delivery is a function of Total current, not duration of current","volume":"38","author":"Gupta","year":"1998","journal-title":"Am J Clin Pharm"},{"key":"10.1177\/0091270010379410-BIB20|cit20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00000539-200110000-00028","article-title":"The concentration-effect relationship of the respiratory depressant effects of alfentanil and fentanyl","volume":"93","author":"Mildh","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1177\/0091270010379410-BIB21|cit21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1213\/00000539-198907000-00005","article-title":"Oral transmucosal fentanyl citrate (lollipop) premedication in human volunteers","volume":"69","author":"Stanley","year":"1989","journal-title":"Anesth Analg"},{"key":"10.1177\/0091270010379410-BIB22|cit22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/00000542-200409000-00023","article-title":"Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate","volume":"101","author":"Kharasch","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1177\/0091270010379410-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1185\/03007990903368310","article-title":"Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain","volume":"25","author":"Rauck","year":"2009","journal-title":"Curr Med Res Opin"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1177%2F0091270010379410","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1177\/0091270010379410\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T12:57:58Z","timestamp":1657803478000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1177\/0091270010379410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1177\/0091270010379410","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}